Catalin Nistor
13Patents
2h-index
8Co-inventors
43Inventor score
Filing activity: Oct 24, 2007 → Jan 27, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8097239B2 | Controlled-release formulations | Human Necessities | 35 | Active |
| US10688148B2 | Formulations containing a somatostatin receptor agonist | Emerging Cross-Sectional Technologies | 4 | Active |
| US9974861B2 | Peptide slow-release formulations | Human Necessities | 2 | Active |
| US9668967B2 | Lipid formulations comprising a thiolated antioxidant | Human Necessities | 1 | Active |
| US9820934B2 | Acid containing lipid formulations | Human Necessities | 1 | Active |
| US11135264B2 | Formulations containing a somatostatin receptor agonist | Emerging Cross-Sectional Technologies | 1 | Active |
| US12246055B2 | Lipid-controlled release compositions | Human Necessities | 0 | Active |
| US12257282B2 | Mixtures and formulations | Emerging Cross-Sectional Technologies | 0 | Active |
| US11433120B2 | Controlled release peptide formulations | Human Necessities | 0 | Active |
| US11369617B2 | Prostacyclin analogue formulations | Human Necessities | 0 | Active |
| US11241476B2 | Mixtures and formulations comprising an alkyl ammonium EDTA salt | Emerging Cross-Sectional Technologies | 0 | Active |
| US11564968B2 | Formulations containing a somatostatin receptor agonist | Emerging Cross-Sectional Technologies | 0 | Active |
| US11672843B2 | Somatostatin receptor agonist formulations | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.